Rxi Pharmaceuticals Corp (NASDAQ:RXII)

1.19
Delayed Data
As of Feb 26
 -0.01 / -0.83%
Today’s Change
0.91
Today|||52-Week Range
6.50
-25.63%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

--

--
AssetsCash--11.4M----
 
 
Short Term Investment Cash4.6M6.3M----
 
 
 
Cash & Short Term Investments5.2M14.4M----
 
 
 
 
ReceivablesReceivables0.000.00------
 
InventoriesInventories----------
 
Current AssetsOther Current Assets212.0K303.0K----
 
 
 
Current Assets5.4M14.7M----
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross783.0K809.0K----
 
 
 
Depreciation-585.0K-632.0K----
 
 
 
Other Assets2.0K18.0K----
 
 
 
Total Assets5.6M14.9M----
 
 
 
 
LiabilitiesAccounts Payable0.00163.0K----
 
 
Short Term Debt5.0K0.00----
 
 
Accrued Expenses364.0K985.0K----
 
 
 
Other Current Liabilities1.3M1.3M----
 
 
 
Other Liabilities1.7M2.1M----
 
 
 
 
Total LiabilitiesTotal Liabilities1.7M2.1M----
 
 
 
 
EquityMinority Interest0.000.00------
Preferred Stock9.7M10.0M----
 
 
 
Common Equity-5.8M2.9M----
 
 
 
Total Shareholder Equity3.9M12.9M----
 
 
 
 
Share InformationCommon Shares Outstanding5.3M11.8M----
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account